The US Generic Drugs Market holds a leading position globally, supported by a mature pharmaceutical industry, high generic prescription rates, and a strong regulatory framework that promotes competition and affordability. Patent expirations of branded drugs continue to create opportunities for generic manufacturers to introduce lower-cost alternatives, helping reduce healthcare spending while...

According to a new report from Intel Market Research, the global Antihypertensive Drugs market was valued at USD 31.96 billion in 2024 and is projected to grow from USD 33.12 billion in 2025 to reach USD 40.62 billion by 2034, exhibiting a CAGR of 3.6% during the forecast period (2025–2034). This steady growth trajectory is underpinned by the escalating global burden of hypertension,...

According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...

According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...

According to a new report from Intel Market Research, the global ibuprofen market was valued at USD 87.4 million in 2024 and is projected to grow from USD 89.9 million in 2025 to USD 106 million by 2032, exhibiting a steady CAGR of 2.9% during the forecast period (2025–2032). This growth is driven by the increasing global burden of chronic pain conditions and inflammatory diseases, rapid...